Document is current

Any future updates will be listed below

Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches

Crossref DOI link: https://doi.org/10.1136/jitc-2021-003928

Published Online: 2022-02-28

Published Print: 2022-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark